Clinical Trials Directory

Trials / Unknown

UnknownNCT04815226

The Role of Active Administration of Peristeen Bowel Evacuation for the Management of Urinary Tract Infection

The Role of Active Administration of Peristeen Bowel Evacuation for the Management of Urinary Tract Infection in Patients With Neurogenic Bladder: a Prospective, Explorative Pilot Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
5 Years – 18 Years
Healthy volunteers
Accepted

Summary

This study investigates whether active use of transanal irrigation (Peristeen®) effectively manages urinary tract infection among patients with the diagnosis of neurogenic bladder.

Detailed description

This study investigates whether active use of transanal irrigation (Peristeen®) effectively manages urinary tract infection among patients diagnosed with neurogenic bladder. It is a prospective exploratory pilot study, and the participants will be asked to perform transanal irrigation twice weekly for 12 weeks (three months). At each visit, including baseline, the study endpoints will be assessed by basic urinalysis, KUB imaging, Seoul Fecal Scoring, and a survey (Korean Neurogenic Bowel Score).

Conditions

Interventions

TypeNameDescription
DEVICEPeristeen Transanal IrrigationUsing Peristeen Transanal Irrigation twice per week for 12 weeks

Timeline

Start date
2021-04-14
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2021-03-24
Last updated
2023-05-06

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04815226. Inclusion in this directory is not an endorsement.